HUVEC-CM prevents VE-cadherin reduction and endothelial hyperpermeability induced by pro-inflammatory mediators.

<p>(A) and (B) HUVEC-CM protected VE-cadherin from VEGF and pro-inflammatory cytokines. The upper panel shows a representative Western blot and the lower panel the densitometry. * indicates <i>P</i> < .05. (C) Analysis of HUVEC-CM effect on endothelial permeability by an in vitro permeability assay with FITC-labeled dextran. Each bar denotes mean ±SD of three independent experiments. * indicates <i>P</i> < .05.